Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novasep Belgium

2000 FOUNDED
M&A STATUS
91-100 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of bio-pharmaceutical products. The company develops recombinant proteins, subunit and live attenuated vaccines, monoclonal antibodies and viral vectors.

Website
Formerly Known As
Henogen
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • Rue Clément Ader 16
  • 6041 Gosselies
  • Belgium

Novasep Belgium Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novasep Belgium‘s full profile, request access.

Request full access to PitchBook